Evolutionary biologic therapy for inflammatory bowel disease.
Hanauer
S B
SB
Pritzker School of Medicine, University of Chicago, 5758 South Maryland Avenue, MC 9028, Chicago, IL 60637, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000628:therapy*; D000069285:Infliximab
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab